Department of Pain Management, The 2nd Affiliated Hospital, Jiangxi Medical College, Nanchang University, No.1 Minde Road, Nanchang, 330006, Jiangxi, China.
JXHC Key Laboratory of Digital Orthopaedics, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, 152 Aiguo Road, Nanchang, 330006, Jiangxi, China.
J Orthop Surg Res. 2024 Jun 15;19(1):356. doi: 10.1186/s13018-024-04781-1.
Ubiquitin/ubiquitin-like (Ub/UBL)-related genes have been reported to be associated with the survival of osteosarcoma patients but have not yet been systematically explored.
The prognostic value of Ub/UBL-related genes, immune cell infiltration and clinicopathological features of patients were explored by Cox and LASSO regression analyses. A prognostic model was established and then validated in the GSE21257 dataset. The differential expression of hub genes in osteosarcoma was confirmed by qRT-PCR, western blotting and immunohistochemistry.
Tripartite Motif Containing 8 (TRIM8) and Ubiquitin Like With PHD And Ring Finger Domains 2 (UHRF2) were screened as genes with prognostic value in osteosarcoma. Kaplan-Meier analysis and scatter plots indicated that patients in the high gene significance score group tended to have a worse prognosis. The concordance index, calibration analysis and receiver operating characteristic analysis suggested that the model had good prediction accuracy and high sensitivity and specificity. Decision curve analysis revealed that patients could obtain greater net benefit from this model. Functional analyses of the differentially expressed genes indicated that they were involved in important functions and pathways. TRIM8 and UHRF2 were confirmed to be highly expressed in osteosarcoma cell lines and tissues.
TRIM8 and UHRF2 are potential prognostic genes in osteosarcoma, and these results provide insights into the roles of these genes and their implications for patient outcomes.
泛素/泛素样(Ub/UBL)相关基因已被报道与骨肉瘤患者的生存有关,但尚未得到系统探索。
通过 Cox 和 LASSO 回归分析探讨 Ub/UBL 相关基因、免疫细胞浸润和患者临床病理特征与预后的关系。建立并验证了预后模型。通过 qRT-PCR、western blot 和免疫组织化学验证骨肉瘤中关键基因的差异表达。
筛选出具有预后价值的基因三结构域蛋白 8(TRIM8)和泛素样含 PHD 和环指结构域 2(UHRF2)。Kaplan-Meier 分析和散点图表明,高基因显著性评分组的患者预后较差。一致性指数、校准分析和受试者工作特征分析表明该模型具有良好的预测准确性和较高的灵敏度和特异性。决策曲线分析表明,该模型可为患者带来更大的净获益。差异表达基因的功能分析表明,它们参与了重要的功能和途径。TRIM8 和 UHRF2 在骨肉瘤细胞系和组织中表达水平较高。
TRIM8 和 UHRF2 是骨肉瘤潜在的预后基因,这些结果为这些基因的作用及其对患者预后的影响提供了新的见解。